Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels

ABSTRACT The level of transcription factor activity critically regulates cell fate decisions, such as hematopoietic stem cell (HSC) self-renewal and differentiation. We introduced STAT5A transcriptional activity into human HSCs/progenitor cells in a dose-dependent manner by overexpression of a tamoxifen-inducible STAT5A(1*6)-estrogen receptor fusion protein. Induction of STAT5A activity in CD34+ cells resulted in impaired myelopoiesis and induction of erythropoiesis, which was most pronounced at the highest STAT5A transactivation levels. In contrast, intermediate STAT5A activity levels resulted in the most pronounced proliferative advantage of CD34+ cells. This coincided with increased cobblestone area-forming cell and long-term-culture-initiating cell frequencies, which were predominantly elevated at intermediate STAT5A activity levels but not at high STAT5A levels. Self-renewal of progenitors was addressed by serial replating of CFU, and only progenitors containing intermediate STAT5A activity levels contained self-renewal capacity. By extensive gene expression profiling we could identify gene expression patterns of STAT5 target genes that predominantly associated with a self-renewal and long-term expansion phenotype versus those that identified a predominant differentiation phenotype.

[1]  E. Vellenga,et al.  Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases. , 2008, Experimental hematology.

[2]  N. Andrews,et al.  Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression. , 2008, Blood.

[3]  U. Klingmüller,et al.  Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2. , 2008, Blood.

[4]  L. Hennighausen,et al.  Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. , 2008, Genes & development.

[5]  Jinshui Fan,et al.  Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML. , 2008, Blood.

[6]  L. Hennighausen,et al.  STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output. , 2007, Experimental hematology.

[7]  E. Vellenga,et al.  Erratum in Schepers et al. Reintroduction of C/EBPα in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis. , 2007, Blood.

[8]  R. Humphries,et al.  Hox genes in hematopoiesis and leukemogenesis , 2007, Oncogene.

[9]  E. Vellenga,et al.  STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells. , 2007, Blood.

[10]  W. Kamps,et al.  Evidence Based Selection of Housekeeping Genes , 2007, PloS one.

[11]  E. Vellenga,et al.  Reintroduction of C/EBPalpha in leukemic CD34+ stem/progenitor cells impairs self-renewal and partially restores myelopoiesis. , 2007, Blood.

[12]  S. Oliviero,et al.  PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation , 2007, Nature Cell Biology.

[13]  K. D. Bunting,et al.  STAT5 signaling in normal and pathologic hematopoiesis. , 2007, Frontiers in bioscience : a journal and virtual library.

[14]  G. Morrone,et al.  Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. , 2007, Experimental hematology.

[15]  C. Pecquet,et al.  Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. , 2007, Blood.

[16]  M. Nostro,et al.  Notch Signaling Induces Apoptosis in Primary Human CD34+ Hematopoietic Progenitor Cells , 2007, Stem cells.

[17]  Frédérick A. Mallette,et al.  The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. , 2007, Genes & development.

[18]  R. V. van Etten,et al.  Molecular Pathogenesis and Therapy of Polycythemia Induced in Mice by JAK2 V617F , 2006, PloS one.

[19]  H. Cavé,et al.  Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. , 2006, Blood.

[20]  B. Porse,et al.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block , 2006, Nature Immunology.

[21]  W. Vainchenker,et al.  JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. , 2006, Blood.

[22]  L. Hennighausen,et al.  Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. , 2006, Blood.

[23]  R. Ilaria,et al.  STAT5 signaling is required for the efficient induction and maintenance of CML in mice. , 2006, Blood.

[24]  R. Levine,et al.  Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model. , 2006, Blood.

[25]  R. McKay,et al.  Notch controls proliferation and differentiation of stem cells in a dose‐dependent manner , 2006, The European journal of neuroscience.

[26]  A. Ganser,et al.  Enhanced sensitivity to inhibition of SHP2, STAT5, and Gab2 expression in chronic myeloid leukemia (CML). , 2006, Blood.

[27]  S. Bohlander,et al.  Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations , 2006, The Journal of experimental medicine.

[28]  E. Vellenga,et al.  STAT5-induced self-renewal and impaired myelopoiesis of human hematopoietic stem/progenitor cells involves down-modulation of C/EBPalpha. , 2005, Blood.

[29]  F. Rosenbauer,et al.  Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. , 2006, Nature immunology.

[30]  S. Chiba,et al.  Notch Signaling in Hematopoietic Stem Cells , 2005, International journal of hematology.

[31]  K. Akashi,et al.  Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. , 2005, Blood.

[32]  S. Akira,et al.  Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis , 2005, The Journal of experimental medicine.

[33]  Andreas Trumpp,et al.  More than just proliferation: Myc function in stem cells. , 2005, Trends in cell biology.

[34]  E. Wagner,et al.  Stat5 tetramer formation is associated with leukemogenesis. , 2005, Cancer cell.

[35]  G. Morrone,et al.  Enforced expression of an Flt3 internal tandem duplication in human CD34+ cells confers properties of self-renewal and enhanced erythropoiesis. , 2005, Blood.

[36]  Pu Zhang,et al.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. , 2004, Immunity.

[37]  G. Morrone,et al.  Enforced Activation of STAT5A Facilitates the Generation of Embryonic Stem–Derived Hematopoietic Stem Cells That Contribute to Hematopoiesis In Vivo , 2004, Stem cells.

[38]  O. Silvennoinen,et al.  STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5. , 2004, Cytokine & growth factor reviews.

[39]  Giovanni Morrone,et al.  Constitutive Activation of STAT5A Promotes Human Hematopoietic Stem Cell Self-Renewal and Erythroid Differentiation , 2004, The Journal of experimental medicine.

[40]  J. Kutok,et al.  Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1 , 2004, Nature Genetics.

[41]  C. Couldrey,et al.  Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness. , 2004, Blood.

[42]  L. Staudt,et al.  Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma. , 2004, Cancer cell.

[43]  M. Goldsmith,et al.  Bone marrow transplant completely rescues hematolymphoid defects in STAT5A/5B-deficient mice. , 2003, Experimental hematology.

[44]  M. Goldsmith,et al.  Transgenic bcl-2 is not sufficient to rescue all hematolymphoid defects in STAT5A/5B-deficient mice. , 2003, Experimental hematology.

[45]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[46]  J. Lammers,et al.  Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. , 2003, Blood.

[47]  Bob Löwenberg,et al.  Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML. , 2003, The hematology journal : the official journal of the European Haematology Association.

[48]  T. Hawley,et al.  Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells. , 2002, Blood.

[49]  W. Hiddemann,et al.  Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells. , 2002, Experimental hematology.

[50]  J. Ihle,et al.  Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. , 2002, Blood.

[51]  M. Goldsmith,et al.  STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. , 2002, Blood.

[52]  H. Lodish,et al.  Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. , 2001, Blood.

[53]  J. Ihle The Stat family in cytokine signaling. , 2001, Current opinion in cell biology.

[54]  Pu Zhang,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.

[55]  E. Vellenga,et al.  Regulation of constitutive STAT5 phosphorylation in acute myeloid leukemia blasts , 2000, Leukemia.

[56]  C. Mantel,et al.  Chemokines, chemokine receptors and hematopoiesis , 2000, Immunological reviews.

[57]  M. Roussel,et al.  Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5. , 2000, Blood.

[58]  W. Leonard,et al.  Essential Role of Signal Transducer and Activator of Transcription (Stat)5a but Not Stat5b for Flt3-Dependent Signaling , 2000, The Journal of experimental medicine.

[59]  M. Loh,et al.  Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. , 2000, Molecular cell.

[60]  A. Mui,et al.  STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.

[61]  H. Lodish,et al.  Fetal Anemia and Apoptosis of Red Cell Progenitors in Stat5a−/−5b−/− Mice A Direct Role for Stat5 in Bcl-XL Induction , 1999, Cell.

[62]  J. Ryan,et al.  Stem cell factor activates STAT-5 DNA binding in IL-3-derived bone marrow mast cells. , 1997, Experimental hematology.

[63]  R. V. van Etten,et al.  P210 and P190BCR/ABL Induce the Tyrosine Phosphorylation and DNA Binding Activity of Multiple Specific STAT Family Members* , 1996, The Journal of Biological Chemistry.

[64]  C. Sawyers,et al.  Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. , 1996, Oncogene.

[65]  J. Griffin,et al.  Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl , 1996, The Journal of experimental medicine.

[66]  B. Groner,et al.  STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. , 1996, Blood.

[67]  B. Groner,et al.  Interleukin-3, Erythropoietin, and Prolactin Activate a STAT5-like Factor in Lymphoid Cells (*) , 1995, The Journal of Biological Chemistry.

[68]  D. Levy,et al.  Thrombopoietin activates a STAT5‐like factor in hematopoietic cells. , 1995, The EMBO journal.

[69]  H. Erdjument-Bromage,et al.  Interleukin‐3 signals through multiple isoforms of Stat5. , 1995, The EMBO journal.

[70]  A. Miyajima,et al.  Interleukin‐3, granulocyte‐macrophage colony stimulating factor and interleukin‐5 transduce signals through two STAT5 homologs. , 1995, The EMBO journal.

[71]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.

[72]  A. Berns,et al.  Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.